Consolidated Balance Sheet (Unaudited) - USD ($) $ in Millions	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 604	$ 1,680
Trade accounts and other receivables	1,987	1,986
Allowance for doubtful accounts	(14)	(8)
Trade accounts and other receivables – net	1,973	1,978
Inventories	201	379
Derivative assets	104	301
Other current assets and deferred charges	272	211
Total current assets	3,154	4,549
Investments	5,107	5,127
Property, plant, and equipment	44,416	44,184
Accumulated depreciation and amortization	(15,230)	(14,926)
Property, plant, and equipment – net	29,186	29,258
Intangible assets – net of accumulated amortization	7,278	7,402
Regulatory assets, deferred charges, and other	1,324	1,276
Total assets	46,049	47,612
Current liabilities:
Accounts payable	1,584	1,746
Accrued liabilities	1,099	1,201
Long-term debt due within one year	1,625	2,025
Total current liabilities	4,308	4,972
Long-term debt	20,801	21,650
Deferred income tax liabilities	2,570	2,453
Regulatory liabilities, deferred income, and other	4,399	4,436
Contingent liabilities and commitments (Note 12)
Stockholders’ equity:
Preferred stock	35	35
Common stock ($1 par value; 1,470 million shares authorized at March 31, 2022 and December 31, 2021; 1,252 million shares issued at March 31, 2022 and 1,250 million shares issued at December 31, 2021)	1,252	1,250
Capital in excess of par value	24,476	24,449
Retained deficit	(13,378)	(13,237)
Accumulated other comprehensive income (loss)	(28)	(33)
Treasury stock, at cost (35 million shares of common stock)	(1,041)	(1,041)
Total stockholders’ equity	11,316	11,423
Noncontrolling interests in consolidated subsidiaries	2,655	2,678
Total equity	13,971	14,101
Total liabilities and equity	$ 46,049	$ 47,612